Solicitors for buying and selling aesthetic clinics

Call 0345 872 6666

‌

Solicitors for buying and selling aesthetic clinics

The acquisition and sale of aesthetic clinics is a fast-growing area of activity within the UK aesthetics sector. However, behind the commercial opportunity sits significant legal and regulatory risk. JMW advises buyers, sellers and investors in the aesthetics sector on risk management and regulatory requirements during clinic transactions, to help you to make the most from your investment.

Without thorough due diligence, buyers purchasing a clinic business may identify unresolved regulatory issues, unclear prescribing arrangements, historic compliance concerns and potential exposure to enforcement action after the transaction has taken place. JMW specialises in advising potential buyers and investors from the valuation process through to completion on your purchase. We will identify any risks or areas of concern, and work to pursue the best possible outcome to resolve each one so that you can buy the business with confidence.

The extent to which historic regulatory liabilities may affect a buyer will depend on the structure of the transaction, including whether the acquisition involves shares in an existing company or the purchase of business assets. 

We have a strong track record of success in providing strategic advice, identifying risk, managing exposure and protecting clients from regulatory, financial and reputational issues arising from acquisitions and disposals. To discuss your needs or learn more about how we can help, call us on 0345 872 6666 or use our online enquiry form to leave us a message and arrange for a call back.

On this page

What our clients say

How JMW can help

JMW's experienced commercial solicitors support individual buyers, private equity firms and others on the acquisition of aesthetic clinics and related businesses. As a full-service law firm with experience in both business transactions across the UK and the regulation of the aesthetics sector, we advise clients across the full lifecycle of aesthetic clinic transactions, including on the fundamental aspects of regulatory compliance. Our services include:

  • Regulatory risk assessment of target businesses
  • Advising on Medicines and Healthcare products Regulatory Agency (MHRA), Care Quality Commission (CQC) and professional regulatory exposure
  • Identifying prescribing and governance risks
  • Reviewing advertising and marketing compliance issues
  • Supporting negotiation of warranties and indemnities
  • Advising on post-completion regulatory issues
  • Coordinating disputes where regulatory and commercial issues overlap

Legal support that combines business and regulatory expertise is vital in these cases, as a failure to account for specific risks can lead to businesses being overvalued, or new owners being subject to regulatory investigations triggered by historic practices. Errors in regulatory compliance can result in reputational damage or unexpected enforcement action post-completion, which can turn an asset into a liability.

With JMW's support, you can properly evaluate risk, seek warranties or address problems before completion, to minimise the risk of regulatory action or commercial disputes between the buyer and the seller. We work closely with colleagues across JMW’s Corporate, Commercial Litigation and Regulatory teams to provide expert advice across any areas that may be of concern.

Meet our team

The expert regulatory team at JMW specialises in regulatory due diligence for aesthetics businesses, and can apply our thorough understanding of both market conditions and regulatory risk to enable you to make a smooth transition into owning or investing in your target business.

Who we help

We advise businesses and organisations across the aesthetics sector, including:

  • Clinic owners looking to sell and needing support during the preparation phase
  • Doctors, dentists and nurses acquiring clinics
  • Private investors and healthcare entrepreneurs
  • Corporate buyers and healthcare groups
  • Medical directors involved in transactions
  • Pharmacy and prescribing businesses expanding into aesthetics

A strategic approach to investment looks at the location, the patient base and opportunities for patient retention, and the tangible assets and equipment that could support additional revenue streams. We can support buyers and investors to evaluate both the potential of an investment and the associated risks to enable them to make decisions with confidence.

What common regulatory issues are uncovered in due diligence?

Aesthetic clinics operate within a highly regulated healthcare environment, and can be a riskier investment than other types of business. This means that when buying or selling a clinic, issues may arise relating to regulatory enforcement by the MHRA or CQC, or compliance with regulatory requirements. Issues can also arise concerning prescribing arrangements, advertising compliance, clinical governance and supply chain integrity that can significantly affect the valuation and viability of a business.

Often, these issues are not immediately visible during a transaction, and thorough due diligence is needed to identify concerns and limit risk. JMW works to identify concerns in any of the following areas that could materially affect valuation and deal structure, so that you can make an informed decision about your investment or work to address risk factors before completion.

MHRA and regulatory exposure

One of the key risks in clinic acquisitions is exposure to historic regulatory non-compliance, particularly where the transaction involves the acquisition of shares in an existing company. The MHRA and other regulators are tightening restrictions on aesthetic practitioners and increasing oversight, which makes strict compliance especially important. A history of MHRA investigations, enforcement action or correspondence can be a key risk, while any ongoing investigations or actions are significantly more serious, as liability risk may continue after completion of the transaction.

There can be serious penalties if the matter concerns supply chains for prescription medicines or the use of unauthorised or counterfeit products, so it is vital to learn as much as possible about the history of your target business and its engagement with the MHRA before completion.

CQC and licensing considerations

Establishing precisely which procedures a target clinic offers, and whether any of them cross into a registrable category, is one of the first things due diligence should establish. Where clinics are within the scope of CQC regulation, buyers must consider whether registration is required and in place - which affects the legality of the services being provided - and whether any previous enforcement action or warning notices could affect the value of the target business.

In England, purely cosmetic treatments such as standard facial botulinum toxin injections and dermal fillers will not ordinarily constitute CQC-regulated activities. However, registration requirements depend on the nature and purpose of the procedures undertaken, and whether they fall within a regulated activity under the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014. Certain surgical procedures and treatments provided for medical purposes may require registration.

Where a transaction involves a change in the legal entity carrying on CQC-regulated activities, appropriate registration arrangements must be made with the CQC to ensure the lawful continuity of services following completion.

Insights into compliance history and inspection outcomes can also enable buyers to establish the risk of post-acquisition regulatory scrutiny and determine any steps they may need to take to bring the business into compliance.

Prescribing and clinical governance arrangements

Prescription-only medicines are central to most aesthetic clinic models and represent a key area of legal risk in transactions. Even where financial records are robust, organisational instability can affect the business' income, especially if a regulator finds reasons to take action.

Key potential issues include:

  • The validity of prescribing arrangements
  • The independence of clinical decision-making
  • Whether prescribing, administration and delegation arrangements comply with applicable legal and professional requirements, including appropriate clinical assessment, supervision and accountability
  • Governance structures between owners and clinicians
  • Compliance with professional regulatory standards

Weak or informal arrangements are a common source of post-acquisition disputes, but can be addressed as part of the purchase process to protect against this risk.

Advertising and reputational risk

Marketing practices are often reviewed during acquisitions, particularly where clinics rely heavily on social media or digital advertising, and advertising practices that breach Advertising Standards Authority requirements (or, in some cases, the law) can leave a buyer exposed.

Advertising breaches can vary in seriousness, depending on their nature and the applicable legal requirements. Particular risks arise from misleading treatment claims, unlawful advertising of prescription-only medicines and non-compliant influencer or third-party marketing arrangements.

What happens if risk factors are not identified before completion?

If you buy or invest in an aesthetic business without carrying out suitable due diligence, you may inherit problems that reduce the clinic’s profitability or require costly remedial work. Depending on the structure of the transaction, historic regulatory breaches may expose the acquired company to enforcement action, whilst ongoing non-compliance may expose the purchaser or operating entity to separate regulatory consequences, including procedure or restriction on services.

There is also the risk of a dispute arising between the buyer and seller. Post-transaction disputes in aesthetics often arise from:

  • Misrepresentation of regulatory compliance status
  • Undisclosed investigations or enforcement history
  • Breach of warranties or indemnities
  • Discovery of unsafe prescribing arrangements
  • Regulatory action following completion
  • Valuation disputes linked to compliance issues

These disputes can escalate into commercial litigation, or the need to pursue alternative dispute resolution to have the situation rectified. However, thorough due diligence supported by appropriate warranties and indemnities in the purchase agreement can identify these risks and protect the buyer before the transaction completes.

FAQs

Q
Can regulatory issues affect an aesthetic clinic's worth?
A

Regulatory issues can reduce an aesthetic clinic’s value by affecting its future income, reputation and potential liabilities.

Key concerns include whether treatments are being provided and prescribed lawfully, whether any required CQC registration is in place, whether advertising complies with the rules, and whether there are historic complaints, claims or enforcement issues. A buyer may also need to spend money correcting non-compliant practices after the purchase. As such, regulatory risk can significantly impact valuation, deal structure and warranty negotiations.

If parts of the clinic’s revenue depend on practices that cannot continue lawfully, those earnings may be worth less when valuing the business. Regulatory problems can therefore reduce the purchase price, and your solicitor may ask for specific warranties, indemnities, or conditions that must be met before completion to protect your investment.

Talk to us

If you are buying or selling an aesthetic clinic or considering an investment in the sector, JMW's specialist team can help you to assess and manage regulatory and legal risks. We advise clients across the UK on transactions in the aesthetics industry, combining regulatory defence expertise with full-service commercial legal support. Early intervention by our team can enable you to separate well-run clinics from higher-risk investments, or evaluate growth potential effectively, to make better investment choices according to your specific goals.

Call JMW today on 0345 872 6666 or use our online enquiry form to get in touch and start the process.